--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About MESO20260417C16
Biological Technology
Mesoblast Limited was established in Australia on June 8, 2004. The company is a world leader in the development of allogeneic cell drugs. The company has built a broad portfolio of commercial and late-stage product candidates utilizing its proprietary mesenchymal spectrum cell therapy technology platform.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
